Literature DB >> 25919235

Random-start ovarian stimulation in patients with cancer.

Hakan Cakmak1, Mitchell P Rosen.   

Abstract

PURPOSE OF REVIEW: Awaiting menses to start ovarian stimulation for oocyte/embryo cryopreservation in patients with cancer may result in a significant delay of cancer treatment that may lead to patients forgoing fertility preservation. The purpose of this review is to describe the new protocols to facilitate the start of ovarian stimulation, including random-start ovarian stimulation. RECENT
FINDINGS: In random-start protocols, the number of total and mature oocytes retrieved, oocyte maturity rate, mature oocyte yield and fertilization rates are similar to those in conventional (early follicular phase start) protocols. Starting ovarian stimulation in the late follicular or luteal phase did not show any superiority against the other. The presence of corpus luteum or luteal phase progesterone levels did not adversely affect synchronized follicular development, number of mature oocytes retrieved, and/or fertilization rates.
SUMMARY: Random-start ovarian stimulation provides a significant advantage by decreasing total time for the IVF cycle, and in emergent settings, ovarian stimulation can be started at a random cycle date for the purpose of fertility preservation without compromising oocyte yield and maturity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25919235     DOI: 10.1097/GCO.0000000000000180

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  23 in total

1.  Successful embryo cryopreservation immediately following a full-term delivery in a woman with newly diagnosed Ewing's sarcoma.

Authors:  Emma Giuliani; Erin M Ellman; Rashmi Chugh; Molly B Moravek
Journal:  J Assist Reprod Genet       Date:  2019-04-05       Impact factor: 3.412

2.  Random start or emergency IVF/in vitro maturation: a new rapid approach to fertility preservation.

Authors:  David Mark Robertson; Robert B Gilchrist; William Leigh Ledger; Angela Baerwald
Journal:  Womens Health (Lond)       Date:  2016-06-01

3.  How effective are the non-conventional ovarian stimulation protocols in ART? A systematic review and meta-analysis.

Authors:  Demian Glujovsky; Romina Pesce; Mariana Miguens; Carlos E Sueldo; Karinna Lattes; Agustín Ciapponi
Journal:  J Assist Reprod Genet       Date:  2020-11-21       Impact factor: 3.412

4.  Folliculogenesis in random start protocols for oocytes cryopreservation: quantitative and qualitative aspects.

Authors:  Giulia Galati; Nicole Serra; Marta Ciaffaglione; Monica Pinna; Marco Reschini; Valerio Pisaturo; Edgardo Somigliana; Ludovico Muzii; Francesca Filippi
Journal:  Reprod Sci       Date:  2022-04-25       Impact factor: 2.924

5.  Specific protocols of controlled ovarian stimulation for oocyte cryopreservation in breast cancer patients.

Authors:  F Cavagna; A Pontes; M Cavagna; A Dzik; N F Donadio; R Portela; M T Nagai; L H Gebrim
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

6.  Fertility preservation outcomes in women with gliomas: a retrospective case-control study.

Authors:  Taylor Nordan; Ann M Thomas; Elizabeth S Ginsburg; Patrick Y Wen; Andrey V Dolinko; Pietro Bortoletto
Journal:  J Neurooncol       Date:  2020-02-14       Impact factor: 4.130

7.  IVF: a short but exciting story.

Authors:  Juan Antonio Garcia Velasco; Emre Seli
Journal:  Curr Opin Obstet Gynecol       Date:  2015-06       Impact factor: 1.927

8.  Does Use of Neoadjuvant Chemotherapy Affect the Decision to Pursue Fertility Preservation Options in Young Women with Breast Cancer?

Authors:  Angelena Crown; Shirin Muhsen; Emily C Zabor; Varadan Sevilimedu; Joanne Kelvin; Shari B Goldfarb; Mary L Gemignani
Journal:  Ann Surg Oncol       Date:  2020-08-07       Impact factor: 5.344

9.  Fertility preservation in post-pubescent female cancer patients: A practical guideline for clinicians.

Authors:  Amirrtha Srikanthan; Eitan Amir; Philippe Bedard; Meredith Giuliani; David Hodgson; Stephanie Laframboise; Anca Prica; Karen Yee; Ellen Greenblatt; Jeremy Lewin; Abha Gupta
Journal:  Mol Clin Oncol       Date:  2017-11-03

10.  Antral follicle responsiveness to FSH, assessed by the follicular output rate (FORT), is altered in Hodgkin's lymphoma when compared with breast cancer candidates for fertility preservation.

Authors:  Charlotte Sonigo; Marjorie Comtet; Solene Duros; Christophe Sifer; Nathalie Sermondade; Michaël Grynberg
Journal:  J Assist Reprod Genet       Date:  2017-10-06       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.